bilobalide has been researched along with Infarction, Middle Cerebral Artery in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, J; Orange, M; Wu, Z; Yang, B; Yao, M; Yi, F; Zheng, Y; Zhu, H | 1 |
Klein, J; Koch, KA; Schwarzkopf, TM | 1 |
Eckert, GP; Hagl, S; Klein, J; Schwarzkopf, TM | 1 |
Biswal, S; Christen, Y; Doré, S; Saleem, S; Zhuang, H | 1 |
Klein, J; Lang, D; Schubert-Zsilavecz, M; Ude, C; Wurglics, M | 1 |
Guan, T; Huang, L; Huang, M; Li, Y; Qian, Y; Tang, X | 1 |
6 other study(ies) available for bilobalide and Infarction, Middle Cerebral Artery
Article | Year |
---|---|
By Activating Akt/eNOS Bilobalide B Inhibits Autophagy and Promotes Angiogenesis Following Focal Cerebral Ischemia Reperfusion.
Topics: Animals; Apoptosis; Autophagy; Brain; Caspase 3; Cyclopentanes; Disease Models, Animal; Furans; Ginkgolides; Infarction, Middle Cerebral Artery; Male; Microtubule-Associated Proteins; Neovascularization, Physiologic; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Vascular Endothelial Growth Factor A | 2018 |
Neurodegeneration after transient brain ischemia in aged mice: beneficial effects of bilobalide.
Topics: Adenosine Triphosphate; Aging; Animals; Brain Infarction; Cyclopentanes; Disease Models, Animal; Extracellular Fluid; Female; Furans; Ginkgolides; Glucose; Glutamic Acid; Infarction, Middle Cerebral Artery; Locomotion; Mice; Microdialysis; Mitochondria; Multienzyme Complexes; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Phosphorylation | 2013 |
Neuroprotection by bilobalide in ischemia: improvement of mitochondrial function.
Topics: Animals; Brain Ischemia; Cyclopentanes; Female; Furans; Ginkgolides; Glucose; Glutamic Acid; Infarction, Middle Cerebral Artery; Mice; Microdialysis; Mitochondria; Neostriatum; Neuroprotective Agents; Oxygen Consumption; Permeability | 2013 |
Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury.
Topics: Animals; Antioxidants; Brain Damage, Chronic; Brain Ischemia; Cells, Cultured; Cerebrovascular Circulation; Cyclopentanes; Drug Evaluation, Preclinical; Enzyme Induction; Excitatory Amino Acid Antagonists; Furans; Ginkgo biloba; Ginkgolides; Glutamic Acid; Heme Oxygenase-1; Infarction, Middle Cerebral Artery; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Plant Extracts; Reperfusion Injury; Response Elements | 2008 |
Brain permeability of bilobalide as probed by microdialysis before and after middle cerebral artery occlusion in mice.
Topics: Animals; Biological Availability; Blood-Brain Barrier; Brain; Chromatography, Liquid; Cyclopentanes; Disease Models, Animal; Female; Furans; Ginkgo biloba; Ginkgolides; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Mass Spectrometry; Mice; Microdialysis; Permeability; Time Factors | 2010 |
Different neuroprotective responses of Ginkgolide B and bilobalide, the two Ginkgo components, in ischemic rats with hyperglycemia.
Topics: Animals; Blood Glucose; Cerebrovascular Circulation; Cyclopentanes; Furans; Ginkgolides; Hyperglycemia; Infarction, Middle Cerebral Artery; Lactones; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2012 |